Ispire Technology Inc. — Q1 Fiscal Year 2027 Earnings Summary

Financial Performance:

• Revenue was $27.5 million, a 9.3% decrease year-over-year from $30.4 million in Q1 fiscal 2026, driven by reduced European sales amid restrictive regulations; revenue increased 3.2% sequentially from $26.7 million in Q4 fiscal 2026.
• Gross profit was $4.5 million compared to $5.1 million in Q1 fiscal 2026; gross margin recovered to 16.2% from 6.3% in the prior quarter and 17.0% in the year-ago period.
• Total operating expenses were $10.6 million, a 35.2% increase year-over-year from $7.8 million, primarily due to a $4.8 million credit loss expense (up $3.0 million from $1.8 million in Q1 2026); expenses decreased 30.4% sequentially from $15.2 million in Q4 fiscal 2026.
• Net loss was $6.4 million ($0.11 per share), narrowing from a $13.8 million loss in Q4 fiscal 2026 and widening from a $3.3 million loss in Q1 fiscal 2026; the current loss includes $4.8 million in credit loss expenses.
• Adjusted EBITDA returned to positive territory at $136,000, an improvement of $2.4 million from a $2.3 million loss in Q4 fiscal 2026, though a decrease of $0.5 million from $0.6 million in Q1 fiscal 2026.
• Cash and restricted cash totaled $15.7 million at September 30, 2026, a decrease of $3.7 million from the fiscal year ended June 30, 2026.
• Working capital was $0.4 million, a decrease of $0.4 million from the prior fiscal year end.
• Net accounts receivable were reduced by approximately 80% from peak levels in fiscal 2025.
• Total liabilities were $87.7 million, down from $93.5 million at June 30, 2026; stockholders' deficit was $(34.8) million compared to $(29.2) million previously.

Guidance and Future Outlook:

• Management expects cash flow to improve as new manufacturing and commercial programs begin to scale during fiscal year 2027.
• The company plans to continue investing in its Malaysia manufacturing facility throughout fiscal year 2027.
• Management anticipates securing a significant OEM and ODM relationship with a well-known regional brand in Southeast Asia and expects to update investors on this deal in the coming months.
• Ike Tech is advancing commercialization efforts, including a planned U.S. pilot of its IKE 2.0 age-gating platform with Charlie's Holdings.
• The company is advancing its nicotine pouch strategy through a joint venture with Jincheng Pharma.

Business Segments and Product Lines:

• The company is expanding global manufacturing capabilities, with a focus on its operations in Malaysia to capitalize on supply-chain diversification.
• The Vapor OEM and ODM pipeline is growing.
• G-Mesh technology and Ispire ONE™ are being developed as part of the company's product portfolio.
• The company holds a 40% ownership stake in IKE Tech, a joint venture focused on age-gating platforms.
• A joint venture with Jincheng Pharma is established for the nicotine pouch market.
• Cannabis vaping hardware is marketed under the Ispire brand on an ODM basis in the U.S., Europe, and South Africa, with recent marketing activities commencing in Canada and Latin America.

Market and Competitive Landscape:

• The European market faces an increasingly restrictive regulatory environment, contributing to reduced sales.
• The company is pursuing supply-chain diversification opportunities in Southeast Asia.
• The company owns or licenses more than 400 patents worldwide.
• Branded e-cigarette products are marketed under the Aspire name globally, excluding the U.S., People's Republic of China, and Russia.

Risks and Challenges:

• Credit loss expenses increased significantly to $4.8 million in the quarter.
• The company faces risks related to the approval or rejection of any PMTA submitted for re-entry into the U.S. ENDS market.
• Uncertainties exist regarding the success of joint ventures with Touch Point Worldwide Inc. (Berify) and Jincheng Pharma.
• Risks include the ability to collect accounts receivable in a timely manner and the success of new products like G-Mesh and Ispire ONE™ in meeting market goals.
• The timing of achieving positive cash flow is uncertain.
• Forward-looking statements highlight risks regarding expansion into the African market and the safety of Ispire ONE™.

Management Commentary and Tone:

• President Steven Przybyla stated the company is building a foundation for its next phase of growth with a stronger manufacturing platform and multiple paths to high-growth markets.
• Management expressed confidence that the company is close to securing a significant OEM/ODM deal in Southeast Asia.
• The tone reflects a focus on stabilizing the business, improving operational efficiency, and strengthening the financial foundation following one-time inventory impairments and returns charges in Q4 fiscal 2026.
• Priorities for fiscal 2027 include executing with discipline, strengthening the balance sheet, and converting investments into lasting shareholder value.

Other Key Points:

• The company held a conference call on November 9, 2026, to discuss results and answer analyst questions.
• A replay of the conference call was available until November 23, 2026.
• The company reported a decrease in cash and working capital from the fiscal year ended June 30, 2026.
• Non-GAAP measures including Adjusted EBITDA are used to assess performance, excluding items such as credit loss expenses, inventory impairments, and stock-based compensation.
• The company's operating subsidiaries own or license over 400 patents worldwide.